Lymphoma development and survival in refractory coeliac disease type II: Histological response as prognostic factor

BACKGROUND: Refractory coeliac disease type II (RCDII) frequently transforms into an enteropathy-associated T-cell lymphoma (EATL) and therefore requires intensive treatment. Current evaluated treatment strategies for RCDII include cladribine (2-CdA) and autologous stem cell transplantation (auSCT)....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:United European Gastroenterol J
Main Authors: Nijeboer, P, van Wanrooij, RLJ, van Gils, T, Wierdsma, NJ, Tack, GJ, Witte, BI, Bontkes, HJ, Visser, O, Mulder, CJJ, Bouma, G
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2016
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5349358/
https://ncbi.nlm.nih.gov/pubmed/28344788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640616646529
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados